Invesco Main Street Fund Class R OMGNX

Medalist Rating as of | See Invesco Investment Hub
  • NAV / 1-Day Return 61.68  /  −2.45 %
  • Total Assets 11.5B
  • Adj. Expense Ratio
    1.060%
  • Expense Ratio 1.060%
  • Distribution Fee Level Below Average
  • Share Class Type Retirement, Medium
  • Category Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.09%
  • Turnover 45%

USD | NAV as of Jun 06, 2026 | 1-Day Return as of Jun 06, 2026, 12:11 AM GMT+0

Morningstar’s Analysis OMGNX

Will OMGNX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

Execution concerns temper confidence in this experienced team.

Associate Analyst Natalia  Arrigoni

Natalia Arrigoni

Associate Analyst

Summary

Continued execution challenges degrade confidence in this strategy’s investment team, prompting a downgrade of the People Pillar rating to Average from Above Average. While the managers retain a sensible philosophy and benefit from Invesco’s broader analyst resources, there have been several years of weak stock selection. For instance, the A’ shares’ 15.9% annualized return in 2025 ranked in the bottom half of the large-blend Morningstar Category. There have been team changes, but to date, they haven’t improved results enough to suggest the team has a consistent edge.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings OMGNX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 48.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

NVIDIA Corp

9.40 1B
Technology

Alphabet Inc Class A

7.93 897M
Communication Services

Apple Inc

6.62 749M
Technology

Microsoft Corp

5.79 654M
Technology

Amazon.com Inc

5.41 611M
Consumer Cyclical

Broadcom Inc

4.17 472M
Technology

JPMorgan Chase & Co

2.98 337M
Financial Services

Meta Platforms Inc Class A

2.64 299M
Communication Services

Philip Morris International Inc

2.21 249M
Consumer Defensive

Eli Lilly and Co

1.76 200M
Healthcare

Sponsor Center